Eastern Mediterranean (WHO region) vs Puerto Rico: Treatment success rate for patients treated for MDR-TB
Eastern Mediterranean (WHO region)
75.0%
in 2022
Puerto Rico
100.0%
in 2020
Eastern Mediterranean (WHO region) rank
4th
Puerto Rico rank
1st
Treatment success rate for patients treated for MDR-TB over time
- Eastern Mediterranean (WHO region)
- Puerto Rico
How they compare
Puerto Rico currently reports 100.0% against 75.0% in Eastern Mediterranean (WHO region), a difference of 25.0%.
That makes Puerto Rico's figure about 1.3 times Eastern Mediterranean (WHO region)'s.
The two have swapped places 3 times across 9 shared years of data; in 2006 it was Eastern Mediterranean (WHO region) ahead.
Eastern Mediterranean (WHO region) ranks 4th and Puerto Rico ranks 1st of 11 groups.
Across the 3 decades both report, Eastern Mediterranean (WHO region) averaged higher in 1 and Puerto Rico in 2.
Head to head by decade
| Decade | Eastern Mediterranean (WHO region) | Puerto Rico | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.3% | 33.3% | 17.0% | Eastern Mediterranean (WHO region) |
| 2010s | 66.4% | 73.4% | 7.0% | Puerto Rico |
| 2020s | 73.0% | 100.0% | 27.0% | Puerto Rico |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Eastern Mediterranean (WHO region) or Puerto Rico?
- Puerto Rico, at 100.0% against 75.0% in Eastern Mediterranean (WHO region) as of 2020.
- What is the difference in treatment success rate for patients treated for mdr-tb between Eastern Mediterranean (WHO region) and Puerto Rico?
- 25.0%, with Puerto Rico ahead.
- How many years of comparable data are there for Eastern Mediterranean (WHO region) and Puerto Rico?
- 9 years are reported by both, from 2006 to 2020.
- How do Eastern Mediterranean (WHO region) and Puerto Rico rank globally for treatment success rate for patients treated for mdr-tb?
- Eastern Mediterranean (WHO region) ranks 4th and Puerto Rico ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.